The Glycated Albumin Assay is an advanced diagnostic tool to monitor glucose levels in patients suffering from diabetes and chronic kidney diseases. Glycated albumin forms when blood glucose binds non-enzymatically and irreversibly to albumin in the blood. It provides a reliable measure of glycemic control over a shorter period of 2-3 weeks, compared to 3 months for HbA1c.
The global Glycated Albumin Assay Market is estimated to be valued at US$ 571 Mn in 2023 ... Read more
